
154OImpact of objective response (OR) on patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA) mutation in the phase III EMBRACA trial
Fasching, P A, Quek, R G W, Bhattacharyya, H, Hurvitz, S A, Rugo, H S, Ettl, JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz100.005
Date:
May, 2019
Fichier:
PDF, 81 KB
2019